Atrion Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ATRI research report →
About the company
Atrion Corporation, along with its affiliated entities, specializes in the development, production, and global distribution of medical devices for fluid management, cardiovascular health, and ophthalmology, reaching markets across the United States, Canada, Europe, and beyond. Its fluid management portfolio includes valves designed to precisely regulate the flow of liquids or gases, vital for various intubation, intravenous, and catheter applications in anesthesia and oncology, and instrumental in promoting infection control in both hospital and home healthcare environments. In the cardiovascular segment, the company offers a Myocardial Protection System that delivers essential fluids and medications, accurately mixes critical drugs, and meticulously controls variables such as temperature and pressure.
- CEO
- David A. Battat
- IPO
- 1980
- Employees
- 712
- HQ
- Allen, TX, US
Price Chart
- Market Cap
- $809.44M
- P/E
- 41.72
- P/S
- 4.78
- P/B
- 3.33
- EV/EBITDA
- 21.40
- Div Yield
- 1.91%
- Gross Margin
- 36.84%
- Op Margin
- 13.33%
- Net Margin
- 11.46%
- ROE
- 8.05%
- ROIC
- 7.89%
- Revenue
- $169.33M · -7.73%
- Net Income
- $19.41M · -44.55%
- EPS
- $11.02 · -43.75%
- Op Income
- $22.58M
- FCF YoY
- 53.24%
- 52W High
- $503.24
- 52W Low
- $274.98
- 50D MA
- $455.95
- 200D MA
- $400.15
- Beta
- 0.69
- Avg Volume
- 27.59K
Get TickerSpark's AI analysis on ATRI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 21, 24 | STUPP JOHN P JR | sell | 879.12 |
| Aug 21, 24 | STUPP JOHN P JR | sell | 135,000 |
| Aug 21, 24 | Spaulding Ronald Nicholas | sell | 2,678 |
| Aug 21, 24 | Spaulding Ronald Nicholas | sell | 312.51 |
| Aug 21, 24 | Athey Preston G | sell | 312.51 |
| Aug 21, 24 | Athey Preston G | sell | 1,368 |
| Aug 21, 24 | Bankes Jeannette | sell | 312.51 |
| Aug 21, 24 | Bankes Jeannette | sell | 186 |
| Aug 21, 24 | BATTAT EMILE A | sell | 150,616 |
| Aug 21, 24 | BATTAT EMILE A | sell | 310.87 |
Our ATRI coverage
Recent articles, reports, and earnings notes.
No research on ATRI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ATRI report →Similar companies
Peers in the same neighborhood.